Neal H Shorstein1, Liyan Liu2, Michael D Waxman3, Lisa J Herrinton2. 1. Departments of Ophthalmology and Quality, Kaiser Permanente, Walnut Creek, California. Electronic address: nshorstein@eyeonsight.org. 2. Division of Research, Kaiser Permanente Northern California, Oakland, California. 3. Department of Ophthalmology, Kaiser Permanente, Fresno, California.
Abstract
PURPOSE: To study the relationship of chemoprophylaxis and other factors with the occurrence of acute, clinical, postoperative macular edema. DESIGN: Retrospective cohort study. The drug regimens consisted of postoperative topical prednisolone acetate (PA) alone or with a nonsteroidal anti-inflammatory drug (NSAID) or intraoperative subconjunctival injection of 2 mg triamcinolone acetonide (TA) alone. PARTICIPANTS: Patients undergoing phacoemulsification at Kaiser Permanente, Diablo Service Area, Northern California, from 2007 through 2013. METHODS: We identified incident macular edema diagnoses that had been recorded 5 to 120 days after phacoemulsification with visual acuity 20/40 or worse and evidence of macular thickening by optical coherence tomography. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained from logistic regression analysis, conditioned on the surgeon and adjusted for year, patient age and race, diabetic retinopathy status, other ocular comorbidities, systemic comorbidities, and posterior capsular rupture status. MAIN OUTCOME MEASURES: Incident rates of acute, clinical, postoperative macular edema. RESULTS: We confirmed 118 cases among 16 070 cataract surgeries (incidence, 0.73%). Compared with PA alone, the OR for the relationship of macular edema with PA+NSAID was 0.45 (95% CI, 0.21-0.95) and that for TA injection was 1.21 (95% CI, 0.48-3.06). The frequency of intraocular pressure spikes of 30 mmHg or more between postoperative days 16 and 45 was 0.6% in the topical PA group, 0.3% in the topical PA+NSAID group (P = 0.13), and 0.8% for the TA group (P = 0.52). Black race was associated with a risk of macular edema (OR, 2.86; 95% CI, 1.41-5.79). CONCLUSIONS: Adding a prophylactic NSAID to PA treatment was associated with a reduced risk of macular edema with visual acuity of 20/40 or worse. The risk and safety of TA injection were similar to those of PA alone. Further research is needed on the prognostic significance of postoperative macular edema, the role of prophylaxis, the risk among black people, and the effectiveness of depot medications.
PURPOSE: To study the relationship of chemoprophylaxis and other factors with the occurrence of acute, clinical, postoperative macular edema. DESIGN: Retrospective cohort study. The drug regimens consisted of postoperative topical prednisolone acetate (PA) alone or with a nonsteroidal anti-inflammatory drug (NSAID) or intraoperative subconjunctival injection of 2 mg triamcinolone acetonide (TA) alone. PARTICIPANTS: Patients undergoing phacoemulsification at Kaiser Permanente, Diablo Service Area, Northern California, from 2007 through 2013. METHODS: We identified incident macular edema diagnoses that had been recorded 5 to 120 days after phacoemulsification with visual acuity 20/40 or worse and evidence of macular thickening by optical coherence tomography. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained from logistic regression analysis, conditioned on the surgeon and adjusted for year, patient age and race, diabetic retinopathy status, other ocular comorbidities, systemic comorbidities, and posterior capsular rupture status. MAIN OUTCOME MEASURES: Incident rates of acute, clinical, postoperative macular edema. RESULTS: We confirmed 118 cases among 16 070 cataract surgeries (incidence, 0.73%). Compared with PA alone, the OR for the relationship of macular edema with PA+NSAID was 0.45 (95% CI, 0.21-0.95) and that for TA injection was 1.21 (95% CI, 0.48-3.06). The frequency of intraocular pressure spikes of 30 mmHg or more between postoperative days 16 and 45 was 0.6% in the topical PA group, 0.3% in the topical PA+NSAID group (P = 0.13), and 0.8% for the TA group (P = 0.52). Black race was associated with a risk of macular edema (OR, 2.86; 95% CI, 1.41-5.79). CONCLUSIONS: Adding a prophylactic NSAID to PA treatment was associated with a reduced risk of macular edema with visual acuity of 20/40 or worse. The risk and safety of TA injection were similar to those of PA alone. Further research is needed on the prognostic significance of postoperative macular edema, the role of prophylaxis, the risk among black people, and the effectiveness of depot medications.
Authors: Paul B Greenberg; Victoria L Tseng; Wen-Chih Wu; Jeffrey Liu; Lan Jiang; Christine K Chen; Ingrid U Scott; Peter D Friedmann Journal: Ophthalmology Date: 2010-10-29 Impact factor: 12.079
Authors: Simon Nicholas; Andrew Riley; Hussain Patel; Bridget Neveldson; Gordon Purdie; Anthony P Wells Journal: Clin Exp Ophthalmol Date: 2006-03 Impact factor: 4.207
Authors: Rohit Varma; Neil M Bressler; Quan V Doan; Michelle Gleeson; Mark Danese; Julie K Bower; Elizabeth Selvin; Chantal Dolan; Jennifer Fine; Shoshana Colman; Adam Turpcu Journal: JAMA Ophthalmol Date: 2014-11 Impact factor: 7.389
Authors: Stephen J Kim; Scott D Schoenberger; Jennifer E Thorne; Justis P Ehlers; Steven Yeh; Sophie J Bakri Journal: Ophthalmology Date: 2015-06-26 Impact factor: 12.079
Authors: Myrthe Dieleman; René J Wubbels; Marina van Kooten-Noordzij; Peter W T de Waard Journal: J Cataract Refract Surg Date: 2011-09 Impact factor: 3.351
Authors: Fernando Paganelli; José A Cardillo; Luiz A S Melo; Anselmo G Oliveira; Mirian Skaf; Rogério A Costa Journal: Ophthalmology Date: 2004-11 Impact factor: 12.079
Authors: Allan A Hunter; Sara P Modjtahedi; Kuumba Long; Robert Zawadzki; Eric K Chin; Jeffrey J Caspar; Lawrence S Morse; David G Telander Journal: J Cataract Refract Surg Date: 2014-02-14 Impact factor: 3.351
Authors: Liyan Liu; Lisa J Herrinton; Stacey Alexeeff; Andrew J Karter; Laura B Amsden; James Carolan; Neal H Shorstein Journal: J Cataract Refract Surg Date: 2019-01-09 Impact factor: 3.351
Authors: Richard S Hoffman; Rosa Braga-Mele; Kendall Donaldson; Geoffrey Emerick; Bonnie Henderson; Malik Kahook; Nick Mamalis; Kevin M Miller; Tony Realini; Neal H Shorstein; Richard K Stiverson; Barbara Wirostko Journal: J Cataract Refract Surg Date: 2016-09 Impact factor: 3.351
Authors: María D Pinazo-Durán; Vicente Zanón-Moreno; José J García-Medina; J Fernando Arévalo; Roberto Gallego-Pinazo; Carlo Nucci Journal: Biomed Res Int Date: 2016-03-14 Impact factor: 3.411